AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Severe Asthma Management and Alport Syndrome Program Collaboration
Exploring the development of highly selective drugs for severe asthma and the collaboration between Fibrocore Therapeutics and the McCade Center to advance the Alport Syndrome program, with a focus on the progress of FIB918 monoclonal antibody towards Phase 1 clinical trials.